Straumann Holding AG (SAUHY)
12.85
-0.08
(-0.62%)
USD |
OTCM |
May 03, 16:00
Straumann Market Cap: 20.49B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 20.49B |
| May 02, 2024 | 20.62B |
| May 01, 2024 | 21.33B |
| April 30, 2024 | 21.49B |
| April 29, 2024 | 24.16B |
| April 26, 2024 | 24.19B |
| April 25, 2024 | 23.66B |
| April 24, 2024 | 24.24B |
| April 23, 2024 | 23.96B |
| April 22, 2024 | 24.03B |
| April 19, 2024 | 23.61B |
| April 18, 2024 | 23.36B |
| April 17, 2024 | 24.11B |
| April 16, 2024 | 24.06B |
| April 15, 2024 | 24.14B |
| April 12, 2024 | 24.17B |
| April 11, 2024 | 25.00B |
| April 10, 2024 | 24.55B |
| April 09, 2024 | 25.14B |
| April 08, 2024 | 24.94B |
| April 05, 2024 | 24.57B |
| April 04, 2024 | 24.35B |
| April 03, 2024 | 24.76B |
| April 02, 2024 | 24.55B |
| April 01, 2024 | 25.30B |
| Date | Value |
|---|---|
| March 28, 2024 | 25.34B |
| March 27, 2024 | 25.62B |
| March 26, 2024 | 25.11B |
| March 25, 2024 | 24.38B |
| March 22, 2024 | 25.29B |
| March 21, 2024 | 26.09B |
| March 20, 2024 | 25.89B |
| March 19, 2024 | 25.51B |
| March 18, 2024 | 25.61B |
| March 15, 2024 | 25.93B |
| March 14, 2024 | 26.34B |
| March 13, 2024 | 26.91B |
| March 12, 2024 | 26.77B |
| March 11, 2024 | 26.58B |
| March 08, 2024 | 27.23B |
| March 07, 2024 | 27.18B |
| March 06, 2024 | 26.52B |
| March 05, 2024 | 25.93B |
| March 04, 2024 | 25.91B |
| March 01, 2024 | 25.72B |
| February 29, 2024 | 25.24B |
| February 28, 2024 | 25.64B |
| February 27, 2024 | 26.21B |
| February 26, 2024 | 26.48B |
| February 23, 2024 | 26.47B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.275B
Minimum
Mar 19 2020
36.07B
Maximum
Nov 09 2021
20.45B
Average
19.77B
Median
Jun 02 2022
Market Cap Benchmarks
| AC Immune SA | 236.37M |
| CRISPR Therapeutics AG | 4.744B |
| Addex Therapeutics Ltd | 9.566M |
| NLS Pharmaceutics Ltd | 5.978M |
| Molecular Partners AG | 130.76M |
Market Cap Related Metrics
| PE Ratio | 74.83 |
| PS Ratio | 7.590 |
| Price to Book Value | 9.372 |
| Price to Free Cash Flow | 58.08 |
| Price | 12.85 |
| Earnings Yield | 1.34% |
| Operating PE Ratio | 44.68 |
| Normalized PE Ratio | 74.83 |